Preventing nausea & vomiting after surgery
Part of Digestive system clinical trials.
This trial tests if adding HRS5580 to standard anti-nausea medicine works better to stop vomiting after surgery. You may qualify if you are at moderate-to-high risk for nausea after general anesthesia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your surgery will last 2 hours or longer under general anesthesia (certain types like gynecological or abdominal surgery)
- You have a body mass index (BMI) between 18 and 28
- You are at high risk for nausea (for example, you are female, have had motion sickness or nausea after surgery before, or do not smoke)
- You can stay in the hospital for at least 3 days after surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if two medicines given together, fosaprepitant and palonosetron, can prevent nausea and vomiting caused by strong chemotherapy given over several days. It's for people who have never had chemo before and are about to start a multi-day treatment for a solid tumor.
This trial tests a combination of methods to prevent nausea and vomiting after gynecological surgery using a laparoscope (a small camera). The study uses acupressure and other supportive care techniques to see if they can reduce post-surgery nausea, which is a common and uncomfortable side effect.
This study tests two medications (fosrolapitant and palonosetron) to prevent severe nausea and vomiting in patients with esophageal or lung cancer who are receiving chemotherapy combined with immunotherapy. If the medications work well, they could help patients feel better during treatment and complete their cancer care more comfortably.
This trial studies whether palonosetron helps prevent nausea and vomiting caused by chemotherapy that has a moderate risk of vomiting. It may help you feel more comfortable during chemo and avoid treatment interruptions from severe nausea.
This study tests whether the medication NEPA (Netupitant and Palonosetron) can prevent nausea and vomiting in people who have had surgery for liver, gallbladder, or pancreatic cancer. It may help those who want to avoid post-surgery sickness.
This trial tests if adding a medication called amisulpride to standard anti-nausea drugs can better prevent vomiting and nausea after gynecologic surgery. It is for women at high risk of postoperative nausea.
Hear when a new Prevention of Postoperative Nausea and Vomiting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.